Process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis- alkoxy-substituted spirocyclic 1H- pyrrolidine-2,4-dione derivatives

US9376374B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9376374-B2
Application numberUS-201314387249-A
CountryUS
Kind codeB2
Filing dateMar 25, 2013
Priority dateMar 28, 2012
Publication dateJun 28, 2016
Grant dateJun 28, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a novel process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives, and also to novel intermediates and starting materials which are produced and/or used in the process according to the invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. Process for preparing a compound of formula (I) in which X represents alkyl, halogen, alkoxy, haloalkyl or haloalkoxy, Y represents hydrogen, alkyl, alkoxy, halogen, haloalkyl or haloalkoxy, where only one of the radicals X or Y may represent haloalkyl or haloalkoxy, A represents C 1 -C 6 -alkyl, R′ represents alkyl, R″ represents alkyl, comprising initially converting a compound of formula (IIa) in the presence of a base into a compound of formula (IIb) in which M represents an alkali metal ion, an ion equivalent of an alkaline earth metal, an ion equivalent of aluminium or an ion equivalent of a transition metal or furthermore represents an ammonium ion where optionally one, two, three or all four hydrogen atoms may be replaced by identical or different radicals from the groups C 1 -C 5 -alkyl, C 1 -C 5 -isoalkyl or C 3 -C 7 -cycloalkyl, each of which may be mono- or polysubstituted by fluorine, chlorine, bromine, cyano, hydroxy or interrupted by one or more oxygen or sulphur atoms, or furthermore represents a cyclic secondary or tertiary aliphatic or heteroaliphatic ammonium ion, for example morpholinium, thiomorpholinium, piperidinium, pyrrolidinium, or in each case protonated 1,4-diazabicyclo[2.2.2]octane (DABCO) or 1,5-diazabicyclo[4.3.0]undec-7-ene (DBU), or furthermore represents a heterocyclic ammonium cation, for example in each case protonated pyridine, 2-methylpyridine, 3-methylpyridine, 4-methylpyridine, 2,4-dimethylpyridine, 2,5-di-methylpyridine, 2,6-dimethylpyridine, 5-ethyl-2-methylpyridine, pyrrole, imidazole, quinoline, quinoxaline, 1,2-dimethylimidazole, 1,3-dimethylimidazolium methylsulphate, or furthermore represents a sulphonium ion, or furthermore represents a magnesium halide cation, n represents the number 1 or 2, and reacted further with a compound of formula (III) in which Hal represents halogen, to give a compound of formula (IV) in which X, Y, A and R′ have the meanings given above, and these are further cyclized to a compound of formula (IX) in which X, Y and A have the meanings given above, and these for their part are reacted with a compound of formula (V) R″—OH  (V) in which R″ has the meanings given above. 2. Process according to claim 1 , where X represents chlorine, bromine, methyl, ethyl, propyl, trifluoromethyl, methoxy, difluoromethoxy or trifluoromethoxy, Y represents hydrogen, chlorine, bromine, methoxy, methyl, ethyl, propyl, trifluoromethyl or trifluoromethoxy, where only one of the radicals X or Y may represent trifluoromethyl, trifluoromethoxy or difluoromethoxy, A represents C 1 -C 6 -alkyl, Hal represents chlorine, bromine, fluorine, iodine, R′ represents C 1 -C 6 -alkyl, R″ represents C 1 -C 6 -alkyl. 3. Process according to claim 1 , where X represents chlorine, bromine, methyl, ethyl, methoxy, trifluoromethyl, trifluoromethoxy or difluoromethoxy, Y represents chlorine, bromine, methyl, ethyl, propyl, methoxy, trifluoromethyl or trifluoromethoxy, where only one of the radicals X or Y may represent trifluoromethyl, trifluoromethoxy or difluoromethoxy, A represents C 1 -C 4 -alkyl, Hal represents chlorine, bromine or fluorine, R′ represents C 1 -C 4 -alkyl, R″ represents C 1 -C 4 -alkyl. 4. Process according to claim 1 , where X represents chlorine, bromine, methyl or trifluoromethyl, Y represents chlorine, bromine or methyl, A represents methyl, ethyl, propyl, butyl or isobutyl, Hal represents chlorine or bromine, R′ represents methyl, ethyl, propyl, butyl or isobutyl, R″ represents methyl, ethyl, propyl, butyl or isobutyl. 5. Process according to claim 1 , where X represents methyl, Y represents methyl, A represents methyl, Hal represents chlorine, R′ represents methyl or ethyl, R″ represents methyl or ethyl. 6. Process according to claim 1 , where X represents methyl, Y represents methyl, A represents methyl, Hal represents chlorine, R′ represents ethyl, R″ represents methyl. 7. Process according to claim 1 , where M represents lithium, sodium, potassium, caesium, magnesium, calcium or represents an ammonium ion in which optionally one, two, three or all four hydrogen atoms may be replaced by identical or different radicals from the groups C 1 -C 5 -alkyl, C 1 -C 5 -isoalkyl or C 3 -C 7 -cycloalkyl, each of which may be mono- or polysubstituted by fluorine, chlorine, bromine, cyano, hydroxy and n represents the number 1 or 2. 8. Process according to claim 1 , where M represents lithium, sodium, potassium, caesium, magnesium or calcium and n represents the number 1 or 2. 9. Process according to claim 1 , where M represents lithium, sodium, potassium or caesium and n represents the number 1. 10. Process according to claim 1 , where M represents sodium and n represents the number 1. 11. Process according to claim 1 , where the base employed is sodium carbonate. 12. Process according to claim 1 , where the base employed is sodium methoxide. 13. Process according to claim 1 , where the base employed is sodium hydroxide. 14. A Compound of formula (IX) in which X represents alkyl, halogen, alkoxy, haloalkyl or haloalkoxy, Y represents hydrogen, alkyl, alkoxy, halogen, haloalkyl or haloalkoxy, where only one of the radicals X or Y may represent haloalkyl or haloalkoxy, A represents C 1 -C 6 -alkyl, R′ represents alkyl, R″ represents alkyl, M represents an alkali metal ion, an ion equivalent of an alkaline earth metal, an ion equivalent of aluminium or an ion equivalent of a transition metal or furthermore represents an ammonium ion where optionally one, two, three or all four hydrogen atoms may be replaced by identical or different radicals from the groups C 1 -C 5 -alkyl, C 1 -C 5 -isoalkyl or C 3 -C 7 -cycloalkyl, each of which may be mono- or polysubstituted by fluorine, chlorine, bromine, cyano, hydroxy or interrupted by one or more oxygen or sulphur atoms, or furthermore represents a cyclic secondary or tertiary aliphatic or heteroaliphatic ammonium ion, for example morpholinium, thiomorpholinium, piperidinium, pyrrolidinium, or in each case protonated 1,4-diazabicyclo[2.2.2]octane (DABCO) or 1,5-diazabicyclo[4.3.0]undec-7-ene (DBU), or furthermore represents a heterocyclic ammonium cation, for example in each case protonated pyridine, 2-methylpyridine, 3-methylpyridine, 4-methylpyridine, 2,4-dimethylpyridine, 2,5-di-methylpyridine, 2,6-dimethylpyridine, 5-ethyl-2-methylpyridine, pyrrole, imidazole, quinoline, quinoxaline, 1,2-dimethylimidazole, 1,3-dimethylimidazolium methylsulphate, or furthermore represents a sulphonium ion, or furthermore represents a magnesium halide cation, n represents

Assignees

Inventors

Classifications

  • Spiro-condensed · CPC title

  • The ring being saturated · CPC title

  • C07C231/12Primary

    by reactions not involving the formation of carboxamide groups · CPC title

  • condensed with carbocyclic rings or ring systems · CPC title

  • C07C233/51Primary

    having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9376374B2 cover?
The present invention relates to a novel process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives, and also to novel intermediates and starting materials which are produced and/or used in the process according to the invention.
Who is the assignee on this patent?
Bayer Ip Gmbh, Bayer Cropscience Ag
What technology area does this patent fall under?
Primary CPC classification C07C231/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).